Divi's Laboratories enterprise value

·Pharma & HealthChart ›
MultiplesEnterprise valuePer share
Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
2,53,300————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
128128415363170
——873——
0.00.02.00.00.0
2,53,172————
−128−128−413−363−170
₹9,553.67————
16,76116,76114,97113,57112,767
0.0%0.0%0.0%0.0%0.0%
22.54×————
63.82×————
72.69×————
1,161.34×————
Reference items — trailing FY values
11,23010,5609,3607,8457,768
3,9673,4412,9682,2052,368
3,4832,9782,5661,8272,025
—2,7381,6531,2612,460
2182182152581,987
—2172152571,987
—2,5201,4381,003473
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

DIVISLAB₹9,558.50

Divi's Laboratories Ltd.

· Pharma & Health
₹ CrorePeersLAURUSLABSCOHANCEGLANDTORNTPHARMZYDUSLIFEMAXHEALTHDRREDDYCIPLAMcap ₹2.53L Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————2,53,300.3
- Cash, Equiv & ST Investments169.7363.0415.0128.0128.0
+ Minority Interest——873.0——
+ Total Debt0.00.02.00.00.0
Enterprise Value————2,53,172.3
Net Debt (memo)-169.7-363.0-413.0-128.0-128.0
EV per Share————9,553.67
Total Capital12,767.113,571.014,971.016,761.016,761.0
Total Debt/Total Capital0.000.000.010.000.00
EV/Sales————22.54
EV/EBITDA————63.82
EV/EBIT————72.69
EV/Free Cash Flow————1,161.34
Reference Items — Trailing FY Values
Sales7,767.57,845.09,360.010,560.011,230.0
EBITDA2,367.82,205.02,968.03,441.03,967.0
EBIT2,024.61,827.02,566.02,978.03,483.0
Operating Cash Flow2,459.71,261.01,653.02,738.0—
Free Cash Flow1,986.7258.0215.0218.0218.0
FCFF (free cash flow to the firm)1,986.6257.5214.5216.8—
Capital Expenditure473.01,003.01,438.02,520.0—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.